Inhibikase Therapeutics, Inc. - IKT
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q4 2025
· Q3 2025
Value (USD)
Total reported value ($000)
$276.4M
QoQ value delta ($000)
+$187.4M
(+210.49%)
Implied price effect (QoQ)
+60.37%
Shares
Total shares
106,415,335
QoQ shares delta
+51,451,208
(+93.61%)
Total shares held by funds (by quarter)
Market chart (IKT)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q4 2025)
Top 25 only
Full list
Early Q1 2026 data: only 4 institutional holders reported so far. More will appear as funds file with the SEC.